BELITE BIO
Live / Allowed — Approved for publication (as of 14 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 04 May 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99803688
- Mark type
- Design + words
- Filed
- 04 May 2026
- Attorney of record
- David A. Bell
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of ophthalmic disorders; Pharmaceutical preparations for the treatment and prevention of metabolic syndromes; Pharmaceutical preparations for the treatment and prevention of cancer
- Class 042 — Scientific and technological services: Pharmaceutical research and development services; Development of pharmaceutical preparations and medicines; research and development of pharmaceuticals for the treatment of ophthalmic disorders, metabolic syndromes, and cancer
Owner
- Belite Bio, Inc, Grand Cayman, KY1-1104, KY
Prior registrations
Prosecution history
- 14 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Sept 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 14 Sept 2026 — EXAMINER'S AMENDMENT ENTERED
- 14 Sept 2026 — EXAMINERS AMENDMENT E-MAILED
- 14 Sept 2026 — EXAMINERS AMENDMENT -WRITTEN
- 08 Sept 2026 — ASSIGNED TO EXAMINER
- 03 Sept 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 03 Sept 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 May 2026 — APPLICATION FILING RECEIPT MAILED
- 04 May 2026 — NEW APPLICATION ENTERED